Birgit Girshick, Corporate Executive VP & COO at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 5,735 shares at $253.78 ($1.5M) on 2023-02-16, disclosed to the SEC on 2023-02-17.
Seasonal sale ($1.5M) by Corporate Executive VP & COO — this insider has traded CRL in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $246.13 | 84 | $21K | 1.4% |
| 2 | $248.07 | 100 | $25K | 1.7% |
| 3 | $249.22 | 73 | $18K | 1.2% |
| 4 | $250.69 | 78 | $20K | 1.3% |
| 5 | $251.56 | 183 | $46K | 3.1% |
| 6 | $252.87 | 157 |
| $40K |
| 2.7% |
| 7 | $253.78 | 219 | $56K | 3.8% |
| 8 | $253.78 | 219 | $56K | 3.8% |
| 9 | $254.55 | 417 | $106K | 7.3% |
| 10 | $254.55 | 417 | $106K | 7.3% |
| 11 | $255.65 | 1,392 | $356K | 24.3% |
| 12 | $255.65 | 1,392 | $356K | 24.3% |
| 13 | $256.48 | 502 | $129K | 8.8% |
| 14 | $256.48 | 502 | $129K | 8.8% |
| Total | $254.87 avg | 5,735 | $1.5M | 100% |
| Filing → |
| CRL | BUY | 2023-11-21 | $497K | — | Filing → |
| CRL | SELL | 2021-09-15 | $2.1M | — | Filing → |
| CRL | SELL | 2021-04-07 | $9.6M | — | Filing → |